Stryker continues to enjoy extensive financial flexibility, even as it has issued more debt to finance the purchase of some larger acquisitions. At the end of 2024, the firm's net debt/EBITDA was 1.9 ...

Robotics has transformed minimally invasive surgery, providing greater precision, less pain, and faster recovery times for ...

Stock analysts at Zacks Research upped their Q2 2026 earnings estimates for shares of AngioDynamics in a research report ...

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

The global laparotomy sponge market is poised for significant growth, with market size projected to surge from USD 1.3 billion in 2024 to an estimated USD 2.3 billion by 2034, reflecting a CAGR of 5.4 ...

The global electrosurgery devices market is poised for significant growth, with its valuation expected to rise from USD 3.4 billion in 2023 to USD 5.3 billion by 2033, expanding at a CAGR of 4.4% ...

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...

Solventum (NYSE:SOLV – Get Free Report) is one of 238 public companies in the “Surgical & medical instruments” industry, but how does it contrast to its rivals? We will compare Solventum to similar ...

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are ...

We recently compiled a list of the 7 Best Medical Technology Stocks To Buy According To Analysts. In this article, we are ...

Since a new CEO moved Surgical Solutions to Kansas City 17 months ago, the company has been making significant strides, ...